Equine Healthcare Market By Product Type (Vaccines {Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines}, Pharmaceuticals {Anti-infectives, Anti-inflammatory Drugs, Parasiticides}, Feed Additives { Nutritional Supplements, Performance Enhancers, Digestive Health Products}, Medical Devices {Diagnostic Devices, Surgical Equipment, Monitoring Devices}), By Disease Type (Infectious Diseases {Equine Influenza, Strangles, Equine Herpesvirus}, Non-Infectious Diseases {Colic, Laminitis, Arthritis}, Parasitic Infections {Internal Parasites, External Parasites}), By Animal Type (Horses, Ponies, Donkeys, Zebras), By End-User (Veterinary Hospitals & Clinics, Diagnostic Laboratories, Rehabilitation Centers, Animal Pharmacies), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Equine Healthcare market accounted for USD 3.58 Billion in 2024 and is expected to reach USD 6.52 Billion by 2035, growing at a CAGR of around 5.6% between 2025 and 2035. Equine Healthcare Market means the business sector that deals with products and services aimed at modifying attrition and enhancing the health of horses.

It encompasses vaccines, pharmaceutical feeds and feed materials, medications, medical devices, diagnostics, and therapies used to control, cure and mitigate diseases in horses. The market is fueled by precious attributes including the rising population of horses across the globe, the rising tendency of people towards these equestrian-related activities and sports, and rising awareness of equine health care.

Report Scope:

Market Dynamics

The growing global horse population drives demand for veterinary and healthcare services

The rising instances of horses around the globe play a key role in the growth of the Equine Healthcare Market due to the health checkups and management of the horses. As more people are employed and retired, the growing population involved in horse racing, recreation, and breeding deserves access to immunizations, medications, and regular health checks. The need for advanced medical products is increasing as horse owners become more conscious of chronic illnesses and their prevention. Also, the growth of related industries and sectors in developing markets highlights the necessity to properly feed, supplement, and monitor these animals.

They are improving horse welfare worldwide, and this trend is being bolstered by advancements in medical devices and artificial intelligence diagnostics. Another contributing factor is the expansion of e-commerce platforms that enable the distribution of health products, connecting those who want to enhance their horses' health with providers of quality products.

Increased awareness of equine disease prevention enhances market expansion

A rising rate of incidence of diseases in equines is the main factor fueling expansion in the Equine Healthcare Market since owners are now more vigilant in seeking preventative care for their horses. Public awareness, innovations in diagnostics, and accessibility to vaccines have enabled owners to appreciate signs of health complications. Vaccines, medicines, and supplements have gained popularity due to the growing knowledge of diseases such as equine influenza, strangles, and laminitis.

More investment in veterinary services and increased use of portable diagnostic tools equally back disease management. This trend is especially prominent in active markets where there is a focus on equine-related industries as enhanced healthcare solutions continue to enhance horse performance and life spans, boosting the industry overall.

Limited veterinary infrastructure in developing regions restricts market penetration

Lack of veterinary setup especially in developing parts of the world hinders the expansion of the Equine Healthcare Market because it can hamper the accessibility of care amongst horses. A lot of rural community’s struggle to recruit veterinary staff and get access to diagnostic services or pharmaceuticals. This causes lots of problems in managing diseases like equine influenza, strangles, and parasitic diseases, among others.

Healthcare facilities in this region lack necessary diagnostic and monitoring instruments, as well as advanced portable devices. Facility owners may not access or implement widely accepted modern healthcare methods. The cost of constructing appropriate infrastructure and education of personnel involved in veterinary services is also a challenge. Therefore, the degree of market penetration for equine healthcare products and services is still relatively small in these regions, which restricts the development of the equine healthcare business.

The rising popularity of e-commerce for equine products creates growth opportunities

Online shopping for horse products is becoming a significant factor driving the growth of the Equine Healthcare Market. Consumers find it much more convenient to purchase products for their horses online instead of traveling to physical stores. Thanks to web technologies, users can easily buy a variety of items, including pet care products, animal feeds, vitamins, veterinary equipment, and other health-related products, all without needing to leave their homes. This ease of access eliminates geographical barriers, particularly in rural areas where finding a veterinary store can be challenging.

Strategic placing services and products online enables companies to give rebates, make recommendations, and sell products per subscription where necessary, for example, feed supplements or parasiticides. The kinds of technologies that are integrated into the organization include artificial intelligent advisors when recommending products to customers and other virtual consultations.

Expansion into emerging markets enhances accessibility to equine healthcare solutions

Market growth is improving access to Equine Healthcare solutions in emerging regions due to the rise in equestrian activities and the increasing horse population. There is a growing awareness of equine health in developing countries across the Asia-Pacific, Latin America, and some parts of Africa, which has led to an increased demand for vaccines, diagnostic tools, and pharmaceuticals. According to recent surveys, multinational companies are now committing resources to establish local manufacturing and distribution networks, as well as collaborations to launch affordable care products in these regions.

Governments around the globe, especially those in emerging economies, are enhancing their capacities in veterinary and producing other strategies to enhance the health of these horses, thereby fueling the growth of this market. Transport of veterinary ambulances, as well as online sources accompanied by applications with teleconsultation and on-demand diagnostics, are expanding equine care accessibility in rural regions. This expansion allows the Equine Healthcare Market to access new markets, creating growth opportunities and improving care solutions for previously unreachable customers.

Industry Experts Opinion

“It is our mission at Zoetis to provide solutions that practitioners can count on; by investing in continued research around equine health and our products, we can provide answers to common questions we receive from equine veterinarians in the field. It is a true differentiator for us and provides confidence in our products for those managing equine health. We are grateful for the industry-leading researchers and universities that help us advance care.”                

•  Dr. Nathan Voris, Director of Equine Technical Services at Zoetis.

"Along with mosquito season comes a rise in potentially fatal mosquito-borne illnesses in horses, including West Nile Virus (WNV) and Eastern Equine Encephalitis (EEE), About 1/3 of affected horses typically those that are unvaccinated may die from [WNV], while more than 90% of unvaccinated horses die from an EEE infection, With both, disease and clinical signs may still occur in horses that are vaccinated but are usually much less severe. However, horses that survive may have permanent neurological deficits.”   

• Amanda Trimble, BVMS, MS, a clinical assistant professor, at Texas A&M College of Veterinary Medicine and Biomedical Sciences

Segment Analysis

Based on Product Type, the Equine Healthcare Market includes vaccines, pharmaceuticals, feed additives, and medical devices. All types of vaccines including inactivated, live attenuated or DNA types are useful in preventing various equine infectious diseases such as influenza and herpesvirus due to improving management strategies.

The growing prevalence of infections, inflammation, and parasites among animals is leading to an increased demand for anti-infectives, anti-inflammatories, and parasiticides. This rise is attributed to more frequent equestrian activities. As horse caregivers aim to ensure optimal health and performance, there is also a growing popularity for supplements, performance enhancers, digestive health products, and nutritional feeds. Additionally, the adoption of diagnostic and surgical instruments and monitoring devices is increasing, thanks in part to advancements in AI-powered monitoring technology.

Based on Diseases, the Equine Healthcare Market is divided into infectious diseases, non-infectious diseases, and parasitic diseases. Equine influenza, strangles, herpesvirus, and other health threats are fundamental to vaccine and diagnostic products due to higher biosecurity standards. Conditions that are not infectious include colic, laminitis, arthritis, etc; these require specific drugs, operations, and feed, resulting from equine life expectancy and enhanced consciousness.

Diseases that can be attributed to internal parasites (for instance worms) and external parasites (for instance) lice are other forces that propel the demand for parasiticides as well as better diagnostic tools. Increased spending on horses by owners from sporting, recreation, and breeding activities are key factors fueling the steady growth of these disease-specific segments.

Regional Analysis

North America is the largest region of the Equine Healthcare Market because of sophisticated veterinary facilities and a large horse population. The United States remains a leading investor in the regional equine vaccines, diagnostics, and pharmaceuticals market. AI-based lameness detection tools, and many others, introduced by such manufacturing companies as Zoetis and Boehringer Ingelheim, are changing equine medicine. Also, awareness of individualized treatment management strategies and strong research activities concerning equine diseases have been improved within the region. Greater awareness regarding equine health by horse owners in the racing and recreation segment also plays a dual role in enhancing market growth. Availability is also boosted by the concrete and persistent presence of e-marketing and capacities from well-developed networks of veterinary clinics.

Asia-Pacific is the fastest-growing region in the Equine Healthcare Market because of increasing interest in equestrian sports and the growing horse population especially in China and India. It has adopted technology including feed additives and small portable diagnostic equipment, which enhances the health of the equines. Firms are now partnering or investing in local production to increase the availability of inexpensive medical technology products. Market demand for equine disease management increases as awareness about these diseases rises; governments’ efforts to improve animal health also fuel the market evolution. There is also a growing shift towards digital veterinary services, and the application of artificial intelligence for diagnostic and therapeutic interventions in equine health across this region also.

Competitive Landscape

The Equine Healthcare Market is expected to have a strong competitive scenario, with market leaders such as Zoetis, Boehringer Ingelheim, and Merck Animal Health. These companies are all about large portfolios, involving vaccines, pharmaceuticals, and diagnostics. Zoetis uses AI in diagnostics related to equine lameness, while Boehringer Ingelheim has applied innovation in vaccination technology and collaboration with technology companies in the innovation of, for example, an AI-based equine health monitoring system.

Proposing to increase the opportunities for veterinary diagnostics, Merck Animal Health focuses on laboratory equipment and individual treatments. Ceva Santé Animale and Elanco for example reinforce themselves through new products in parasiticides and feed additives.

Market entrants of modest size, such as Dechra Pharmaceuticals and Virbac, are finding their specific positions in equine nutrition as well as in therapeutic products. One of the strongest trends is the use of solutions and online stores by companies like IDEXX Laboratories to increase sales and improve supply chains.

Other changes concern the market structure, including cooperation with the leading marketing organizations for the enhancement of advanced research. Leading equine businesses are using AI and a more specific approach to veterinary medicine. While striving to meet customer needs, it identifies areas where solutions are needed; disease prevention and product needs; are consistent with the pursuit of innovation in a highly competitive milieu.

Equine Healthcare Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In October 2024, The American Association of Equine Practitioners (AAEP) published guidelines on its website to help practitioners diagnose acute neurologic cases in adult horses. Practitioners should approach these cases cautiously and consider contagious diseases, such as Equine Herpesvirus-1, and public health threats like Rabies, West Nile Virus, and Eastern Equine Encephalitis.
• In September 2024, Zoetis Inc. announced findings from recently completed research studies focused on the short- and long-term effects of commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) on the final composition of regenerative medicine devices Pro-Stride APS and Restigen PRP, often used to manage equine osteoarthritis (OA), tendonitis and ligament injury.

Report Coverage:

By Product Type

• Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • DNA Vaccines
• Pharmaceuticals
  • Anti-infectives
  • Anti-inflammatory Drugs
  • Parasiticides
• Feed Additives
  • Nutritional Supplements
  • Performance Enhancers
  • Digestive Health Products
• Medical Devices
  • Diagnostic Devices
  • Surgical Equipment
  • Monitoring Devices

 By Disease Type

• Infectious Diseases
  • Equine Influenza
  • Strangles
  • Equine Herpesvirus
• Non-Infectious Diseases
  • Colic
  • Laminitis
  • Arthritis
• Parasitic Infections
  • Internal Parasites
  • External Parasites

By Animal Type

• Horses
• Ponies
• Donkeys
• Zebras

End Users

• Veterinary Hospitals & Clinics
• Diagnostic Laboratories
• Rehabilitation Centers
• Animal Pharmacies

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Zoetis
• Boehringer Ingelheim Animal Health
• Merck Animal Health
• Ceva Santé Animale
• Merial
• Purina Animal Nutrition LLC
• Carrington Animal Health
• Nutrena
• Kentucky Performance Products
• Pro Equine
• Bimeda Animal Health
• Dechra Pharmaceuticals
• Elanco Animal Health
• Bayer Animal Health
• Vetoquinol
• IDEXX Laboratories
• Manna Pro Products
• Virbac

Frequently Asked Questions (FAQs)